NCT06714032View on ClinicalTrials.gov

Effect of Traditional Chinese Medicine of Severe COVID-19

PHASE3CompletedINTERVENTIONAL
Enrollment

172

Participants

Timeline

Start Date

January 29, 2023

Primary Completion Date

November 8, 2023

Study Completion Date

January 25, 2024

Conditions
Severe COVID-19
Interventions
DRUG

TCM plus conventional drug

All patients were treated according to international guidelines. The Experimental group will receive TCM according to the TCM syndrome.

DRUG

TCM placebo plus conventional drug

All patients were treated according to international guidelines. The control group will receive TCM placebo according to the TCM syndrome.

Trial Locations (1)

450000

The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou

All Listed Sponsors
lead

Henan University of Traditional Chinese Medicine

OTHER